Literature DB >> 23237992

SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.

Run-Xuan Shao1, Leiliang Zhang, Zhi Hong, Kaku Goto, Du Cheng, Wen-Chi Chen, Nikolaus Jilg, Kattareeya Kumthip, Dahlene N Fusco, Lee F Peng, Raymond T Chung.   

Abstract

Suppressor of cytokine signaling 1 (SOCS1) and suppressor of cytokine signaling 3 (SOCS3) have been thought to block type I interferon (IFN) signaling. We have previously reported that SOCS3 suppresses HCV replication in an mTOR-dependent manner. However, the relationship between SOCS1 and HCV replication remains unclear. Here, we found that overexpression of SOCS1 alone did not have an effect on HCV RNA replication. However, suppression of HCV replication by IFN-α was rescued by SOCS1 overexpression. The upregulation of HCV replication by SOCS1 overexpression in the presence of IFN is likely a result of the impairment of IFN signaling by SOCS1 and subsequent induction of ISGs. Knockdown of SOCS1 alone with specific shRNA enhanced the antiviral effect of IFN compared with negative control. Thus, SOCS1 acts as a suppressor of type I IFN function against HCV.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237992      PMCID: PMC3764487          DOI: 10.1016/j.antiviral.2012.12.001

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  27 in total

1.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

2.  JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.

Authors:  B Sporri; P E Kovanen; A Sasaki; A Yoshimura; W J Leonard
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

Review 3.  Viral exploitation of host SOCS protein functions.

Authors:  Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

Review 4.  The JAK-STAT pathway at twenty.

Authors:  George R Stark; James E Darnell
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C.

Authors:  Virginia Sedeño-Monge; Gerardo Santos-López; Rosa C Rocha-Gracia; Daniel Meléndez-Mena; Alberto Ramírez-Mata; Verónica Vallejo-Ruiz; Julio Reyes-Leyva
Journal:  Virol J       Date:  2010-09-18       Impact factor: 4.099

7.  SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases.

Authors:  Minoru Fujimoto; Tetsuji Naka
Journal:  Gastroenterol Res Pract       Date:  2010-09-02       Impact factor: 2.260

8.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

9.  Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.

Authors:  Jonathan Moorman; Zhi P Dong; Lei Ni; Chunlan Zhang; Thomas Borthwick; Zhi Q Yao
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

Review 10.  Anti-hepatitis C virus drugs in development.

Authors:  Esperance A K Schaefer; Raymond T Chung
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

View more
  10 in total

1.  KPP: KEGG Pathway Painter.

Authors:  Ganiraju Manyam; Aybike Birerdinc; Ancha Baranova
Journal:  BMC Syst Biol       Date:  2015-04-15

2.  ATM supports gammaherpesvirus replication by attenuating type I interferon pathway.

Authors:  Eric J Darrah; Kyle P Stoltz; Mitchell Ledwith; Vera L Tarakanova
Journal:  Virology       Date:  2017-07-18       Impact factor: 3.616

3.  IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.

Authors:  Adeola A Obajemu; Nina Rao; Kari A Dilley; Joselin M Vargas; Faruk Sheikh; Raymond P Donnelly; Reed S Shabman; Eric G Meissner; Ludmila Prokunina-Olsson; Olusegun O Onabajo
Journal:  J Immunol       Date:  2017-10-25       Impact factor: 5.422

4.  Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.

Authors:  Bing Liu; Shan Chen; Yujuan Guan; Limin Chen
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

Review 5.  IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research.

Authors:  Bing Liu; Ian McGilvray; Limin Chen
Journal:  Gastroenterol Res Pract       Date:  2015-05-20       Impact factor: 2.260

6.  SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.

Authors:  Rabia Aslam; Syed Mohsin Raza; Humeira Naeemi; Bushra Mubarak; Nadeem Afzal; Saba Khaliq
Journal:  Springerplus       Date:  2016-10-21

7.  Integrative analysis of differentially expressed microRNAs of pulmonary alveolar macrophages from piglets during H1N1 swine influenza A virus infection.

Authors:  Pengfei Jiang; Na Zhou; Xinyu Chen; Xing Zhao; Dengyun Li; Fen Wang; Lijun Bi; Deli Zhang
Journal:  Sci Rep       Date:  2015-02-02       Impact factor: 4.379

8.  The Coronavirus PEDV Evades Type III Interferon Response Through the miR-30c-5p/SOCS1 Axis.

Authors:  Changlin Wang; Lingling Shan; Shuxin Qu; Mei Xue; Keliang Wang; Fang Fu; Lu Wang; Ziqi Wang; Li Feng; Wanhai Xu; Pinghuang Liu
Journal:  Front Microbiol       Date:  2020-05-22       Impact factor: 5.640

9.  Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection.

Authors:  Yung-Ju Yeh; Ching-Ping Tseng; Sheng-Da Hsu; His-Yuan Huang; Michael M C Lai; Hsien-Da Huang; Ju-Chien Cheng
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

10.  Coxsackievirus B3 Infection of Human Neural Progenitor Cells Results in Distinct Expression Patterns of Innate Immune Genes.

Authors:  Soo-Jin Oh; Jeong-An Gim; Jae Kyung Lee; Hosun Park; Ok Sarah Shin
Journal:  Viruses       Date:  2020-03-17       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.